Insider trading

Period: 120 months Stock: ELVN Minimum amount: $1M × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

32 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

32 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

32 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

32 decisions over 120 months Remove this filter
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
32 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
32 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

32 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
4 Aug 2026
Derynck Mika K Director
Sold on a plan
$9.56M 158,795 at 60.21
100%
Sold half or more
22 Jun 2026
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will 4×
$39.01M 860,123 at 45.36
79.7%
Sold half or more
15 Jun 2026
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will 2×
$12.67M 281,408 at 45.02
53.4%
Sold half or more
25 Mar 2026
Collins Helen Louise CHIEF MEDICAL OFFICER
Sold on a plan
$1.40M 40,000 at 35.10
61.5%
Sold half or more
17 Feb 2026
Collins Helen Louise CHIEF MEDICAL OFFICER
Sold on a plan
$1.18M 45,000 at 26.17
64.3%
Sold half or more
9 Jan 2026
Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER · indirect
Sold on a plan 2×
$2.48M 91,198 at 27.22
10.6%
Planned (10b5-1)
9 Jan 2026
Patel Anish CHIEF OPERATING OFFICER · indirect
Sold on a plan 2×
$1.35M 48,300 at 27.99
18.3%
Planned (10b5-1)
9 Oct 2024
Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER · indirect
Sold on a plan 2×
$1.07M 37,878 at 28.16
3.6%
Planned (10b5-1)
16 May 2024
ORBIMED ADVISORS LLC Director · indirect
Sold at will 2×
$22.88M 1,033,300 at 22.14
80.2%
Sold half or more
16 May 2024
Gupta Rishi Director · indirect
Sold at will 2×
$22.88M 1,033,300 at 22.14
80.2%
Sold half or more
11 Apr 2024
Ballal Rahul D. Director
Sold on a plan 3×
$1.28M 53,400 at 23.95
70.5%
Sold half or more
11 Apr 2024
Kintz Samuel PRESIDENT AND CEO
Sold on a plan
$1.19M 47,709 at 25.04
100%
Sold half or more
14 Feb 2024
5AM Partners VI, LLC 10% owner · indirect
Sold at will 2×
$12.29M 825,000 at 14.90
56.5%
Sold half or more
31 Jan 2024
5AM Partners VI, LLC 10% owner · indirect
Sold at will 2×
$7.50M 500,000 at 15.00
39.3%
Not planned
26 Sep 2023
5AM Partners VI, LLC 10% owner · indirect
Sold at will 2×
$2.96M 197,500 at 15.00
18.8%
Not planned
24 Aug 2023
5AM Partners VI, LLC 10% owner · indirect
Sold at will 2×
$7.04M 440,000 at 16.00
33.1%
Not planned
4 Jan 2023
Leonard Braden Michael 10% owner · indirect
Sold, plan not stated
$5.00M 1,250,000 at 4.00
41.4%
3 Jan 2023
RA CAPITAL MANAGEMENT, L.P. 10% owner · indirect
Bought
$2.52M 629,297 at 4.00
19.4%
Largest buy in 3 yrs
16 Jul 2021
Bonita David P Director · indirect
Bought
$10.00M 1,666,666 at 6.00
opened
First buy on file
16 Jul 2021
ORBIMED ADVISORS LLC Director · indirect
Bought
$10.00M 1,666,666 at 6.00
opened
First buy on file
16 Jul 2021
Chin Mark Director · indirect
Bought
$8.00M 1,333,333 at 6.00
132%
First buy on file
16 Mar 2020
RA CAPITAL MANAGEMENT, L.P. 10% owner · indirect
Bought
$10.00M 625,000 at 16.00
75.4%
First buy on file
16 Mar 2020
Bought
$7.60M 475,000 at 16.00
13.4%
First buy on file
16 Mar 2020
Dalton Barbara Director · indirect
Bought
$5.00M 312,500 at 16.00
25.1%
First buy on file
16 Mar 2020
PFIZER INC 10% owner · indirect
Bought
$5.00M 312,500 at 16.00
26.7%
First buy on file
16 Mar 2020
Rock Springs Capital Management LP 10% owner · indirect
Bought
$4.00M 250,000 at 16.00
91.4%
First buy on file
16 Mar 2020
Arix Bioscience plc 10% owner · indirect
Bought
$3.00M 187,500 at 16.00
13.7%
First buy on file
16 Mar 2020
Bought
$3.00M 187,500 at 16.00
15.1%
First buy on file
16 Mar 2020
Chin Mark Director · indirect
Bought
$3.00M 187,500 at 16.00
13.7%
First buy on file
16 Mar 2020
Agger Mette Kirstine Director · indirect
Bought
$3.00M 187,500 at 16.00
15.1%
First buy on file
12 Mar 2020
Bonita David P Director · indirect
Bought
$15.00M 937,500 at 16.00
opened
First buy on file
12 Mar 2020
ORBIMED ADVISORS LLC Director · indirect
Bought
$15.00M 937,500 at 16.00
opened
First buy on file
Showing 1–32 of 32.